Intersect Ent Equity 2024

Intersect Ent Aktienanalyse

What does Intersect Ent do?

Intersect ENT Inc. is a biotechnology company specializing in the development of innovative therapies and devices for the treatment of chronic sinusitis and other nasal cavity disorders. The company was founded in 2003 and is headquartered in Menlo Park, California. The company's history began with the development of a novel implant system designed to provide effective and gentle treatment for chronic sinusitis. In 2012, the first product called PROPEL mini was launched, which serves as a two-part system for placement in the patient's sinuses. The implant ensures faster recovery after delicate surgeries and prevents adhesions. This innovation has revolutionized the way chronic sinusitis is treated. The PROPEL technology consists of a biodegradable polymer that gradually breaks down in the patient's body. It is available in various sizes and shapes to cater to the individual needs of each patient. In addition to the PROPEL technology, Intersect ENT also has other products in their portfolio targeting nasal cavity disorders. These include the SINUVA implant, used in patients with nasal polyps, as well as various devices for nasal perforation. Intersect ENT's business strategy is focused on maintaining and expanding their leadership in nasal healthcare innovation. The company heavily invests in research and development to create new products and technologies that meet medical needs and can improve patients' lives. To promote the sale of their products, Intersect ENT has built a comprehensive distribution network consisting of their own sales representatives and independent contract partners. The company collaborates closely with medical professionals and healthcare facilities to test and validate the effectiveness of their products. Intersect ENT is a company with a clear focus on innovation and excellence in product development. Their goal is to revolutionize the treatment of nasal diseases while providing patients with a better quality of life. With their groundbreaking technologies and extensive expertise, Intersect ENT has become a leading provider of nasal cavity solutions and is highly esteemed in the industry. Intersect Ent ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Intersect Ent's Equity

Intersect Ent's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Intersect Ent's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Intersect Ent's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Intersect Ent's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Intersect Ent’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Intersect Ent stock

What is the equity of Intersect Ent this year?

Intersect Ent has equity of -69.07 M USD this year.

What was the equity of Intersect Ent compared to the previous year?

The equity of Intersect Ent has increased/decreased by 0% decreased compared to the previous year.

What impact does a high equity have on investors of Intersect Ent?

A high equity is advantageous for investors of Intersect Ent as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Intersect Ent?

A low equity can be a risk for investors of Intersect Ent, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Intersect Ent affect the company?

An increase in equity of Intersect Ent can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Intersect Ent affect the company?

A reduction in equity of Intersect Ent can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Intersect Ent?

Some factors that can affect the equity of Intersect Ent include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Intersect Ent so important for investors?

The equity of Intersect Ent is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Intersect Ent take to change the equity?

To change equity, Intersect Ent can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Intersect Ent pay?

Over the past 12 months, Intersect Ent paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Intersect Ent is expected to pay a dividend of 0 USD.

What is the dividend yield of Intersect Ent?

The current dividend yield of Intersect Ent is .

When does Intersect Ent pay dividends?

Intersect Ent pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Intersect Ent?

Intersect Ent paid dividends every year for the past 0 years.

What is the dividend of Intersect Ent?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Intersect Ent located?

Intersect Ent is assigned to the 'Health' sector.

Wann musste ich die Aktien von Intersect Ent kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Intersect Ent from 10/10/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/10/2024.

When did Intersect Ent pay the last dividend?

The last dividend was paid out on 10/10/2024.

What was the dividend of Intersect Ent in the year 2023?

In the year 2023, Intersect Ent distributed 0 USD as dividends.

In which currency does Intersect Ent pay out the dividend?

The dividends of Intersect Ent are distributed in USD.